SAN FRANCISCO--(BUSINESS WIRE)--Clinical research outcomes of the Synchrony® dual optic accommodating intraocular lens (IOL) were featured in ten podium presentations, two posters, and one film at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS). The Synchrony IOL is not approved for commercial marketing in the U.S. and is available only through an Investigational Device Exemption study.
